An experimental ebola vaccine

An experimental ebola vaccine.
Early results suggest an hypothetical Ebola vaccine triggers an untouched response and is safe to use. However, larger clinical trials in West Africa are needed to verify if the immune response generated by the vaccine is large enough to protect against Ebola infection, said the researchers at Oxford University in the UK This vaccine clockwork against the Zaire labour of Ebola currently circulating in West Africa menjual. It doesn't contain contagious Ebola virus material, so it cannot cause Ebola infection in people who receive it.

The vaccine is being developed by the US National Institutes of Health and GlaxoSmithKline. The beginning doses of the vaccine for use in large-hearted clinical trials in West Africa have been delivered to Liberia. The Oxford University suffering included 60 healthy volunteers who were monitored for 28 days after receiving three many doses of the vaccine. The volunteers will continue to be monitored for six months bizarro. "The vaccine was well tolerated.